
Spondylodiscitis has become a global challenge due to complex aetiology, insidious onset, and rising incidence, yet large-scale epidemiological trend data are lacking and no standardised diagnostic workflow exists internationally, resulting in widespread empirical therapy and delayed targeted treatment. This study aimed to analyse annual changes and epidemiological trends in the pathogen spectrum of spondylodiscitis over three years and to evaluate the diagnostic performance and accuracy of different microbiological detection methods, including conventional culture, metagenomic next-generation sequencing(mNGS), and targeted serological assays. In this single-centre study from April 2022 to June 2025, 1380 consecutive adult patients with spondylodiscitis had lesion specimens submitted for conventional culture, of whom 482 also underwent mNGS. The three-year period was divided into three 12-month intervals to analyse temporal trends in pathogen distribution at species and genus levels by both culture and mNGS, together with targeted serological tests (T-SPOT.TB, standard agglutination test for brucellosis, and fungal biomarkers when indicated). Clinical outcomes following the diagnostic workflow were also assessed. A total of 1380 patients were included (mean age 59.2 ± 14.3 years, 59.5
Although Neisseria meningitidis (N. meningitidis) is classically associated with invasive meningococcal disease, it has emerged as an underrecognized cause of urethritis among populations at increased risk for gonorrhea. Because urogenital N. meningitidis infection can clinically resemble gonococcal urethritis and may not be routinely identified, epidemiologically important lineages and antimicrobial resistance (AMR)-associated determinants may remain underrecognized. Such infections have been sporadically reported in China, but their genomic diversity, evolutionary relationships, and AMR characteristics remain poorly characterized. Fourteen N. meningitidis isolates collected from urethral and pharyngeal specimens in Shanghai and Guangzhou were analyzed using antimicrobial susceptibility testing (AST), whole-genome sequencing (WGS), and phylogenetic analysis. Pan-genome and recombination analyses were further performed to characterize genomic variation and investigate the evolutionary patterns of the predominant lineages, ST-1466 and ST-11,026. Among the 14 isolates (10 urogenital and 4 pharyngeal), six distinct STs were identified, with ST-1466 (6/14) and ST-11,026 (3/14) predominating. The Chinese urogenital ST-1466 isolates clustered within the North American lineage (Cluster B) but displayed an AMR profile more similar to those of Cluster A isolates. Recombination analysis identified lineage-specific genomic regions in ST-1466, including loci involved in iron acquisition and metabolism. The Chinese and Japanese urogenital ST-11,026 isolates formed a closely related cluster and were resistant to ciprofloxacin (CIP), whereas the urogenital ST-3200 isolate clustered with other Chinese isolates. Most isolates were resistant to penicillin (PEN) and trimethoprim–sulfamethoxazole (SXT). Notably, one pharyngeal isolate showed reduced susceptibility to third-generation cephalosporins and harbored the rare pen842 allele. Urogenital-associated N. meningitidis lineages may be circulating in China, with some isolates being genetically related to internationally reported lineages and carrying AMR-associated determinants. Recombination involving genes related to iron acquisition and metabolism may reflect ongoing genomic diversification, although its contribution to urogenital adaptation requires functional validation. These findings highlight the importance of strengthened genomic surveillance and routine AST of N. meningitidis isolates recovered from urogenital infections.
Carbapenem-resistant Pseudomonas aeruginosa (CRPA) is a major global nosocomial pathogen, and the emergence of difficult-to-treat resistance (DTR-PA) has further constrained therapeutic options. In China, Fujian Province has consistently reported a high burden of CRPA, yet large-scale multicenter genomic surveillance data remain limited. A total of 215 non-duplicate clinical CRPA isolates were collected from nine cities between June and December 2022. Antimicrobial susceptibility testing (AST), whole-genome sequencing (WGS), and phylogenetic analysis were performed to evaluate resistance profiles, clonal distributions, and molecular mechanisms. Among the 215 isolates, 32.6
Tuberculosis (TB) and non-tuberculous mycobacterial (NTM) detections pose overlapping diagnostic and therapeutic challenges, particularly in high-burden regions. Detailed molecular epidemiological data from tertiary care settings in Jiangxi Province, southern China, remain limited, hindering tailored control strategies. This single-center study retrospectively analyzed 83 respiratory specimens positive for Mycobacterium tuberculosis complex (MTC) by Xpert MTB/RIF. Targeted next-generation sequencing (tNGS) was performed to detect MTC and NTM, profile drug resistance-associated mutations, and assess host NAT2 acetylator genotypes. MTC/NTM co-detection occurred in 26.7
Tuberculosis remains a major global health challenge, underscoring the need for rapid and accessible diagnostic tools suitable for resource-limited settings. In this study, we developed and clinically evaluated two LAMP-based CRISPR diagnostic pipelines targeting the IS6110 sequence of Mycobacterium tuberculosis. Two two-pot LAMP-CRISPR diagnostic pipelines were developed and evaluated: one based on Cas12a-mediated DNA detection and one based on Cas13a-medaited RNA detection following in vitro transcription (IVT). Analytical sensitivity was determined using serial dilutions of commercial M. tuberculosis DNA controls. Clinical validation was performed using 76 culture-characterized clinical spiecimens, including respiratory and extra-pulmonary samples, and assay performance was assessed using fluorescence and lateral flow readouts. Both pipelines achieved a limit of detection of 10 copies/µL and showed high specificity (100